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Bioactive macro/micro porous silk fibroin/ 
nano-sized calcium phosphate scaffolds with 
potential for bone-tissue-engineering applications
Bone tissue engineering requires the development 
of three-dimensional porous scaffolds with 
osteogenic properties [1]. Calcium phosphate-
based (CaP) inorganic components have shown 
their osteogenesis potential in bone regeneration 
[2,3]. However, the fragile nature and slow 
degradation profile limit the application of 
these ceramic scaffolds. Combining natural or 
synthetic polymer with calcium phosphate is a 
promising strategy for bone-tissue-engineering 
scaffolding. A great deal of degradable polymers 
have been explored for this purpose [4]. Among 
those, silk f ibroin (SF), derived from the 
silkworm Bombyx mori, has been considered 
as a versatile biomaterial for tissue-engineering 
applications [5–13].
Regarding the preparation of silk/CaP 
composite scaffolds, there are some challenging 
issues that need to be resolved. For instance, it is 
crucial to achieve good affinity between SF and 
CaP particles, as well as to maintain the porous 
structure and mechanical properties of the 
scaffold. On the other hand, the aggregation of 
CaP particles in the scaffold must be prevented. 
Furthermore, it is also important to achieve 
homogeneous distribution of the CaP particles 
inside the scaffold, both at macroscopic and 
microscopic scales. Many attempts have been 
made to improve the interface compatibility of 
the two phases in the scaffolds. Oliveira et al.
synthesized hydroxyapatite (HA) in SF by the 
addition of phosphate ions into the calcium 
chloride/ethanol/water solution with dissolved 
SF [14]. This strategy allowed the formation 
of nano-sized HA inside the SF matrix. Kim 
et al. prepared aqueous-derived salt-leached 
SF scaffolds with the addition of polyaspartic 
acid, followed by the consecutive immersion of 
the scaffolds in calcium chloride and sodium 
phosphate monobasic solutions in order to form 
calcium phosphate crystal on the surface of the 
scaffolds [15]. The introduction of polyaspartic 
acid compromised the mechanical properties 
of the scaffolds. Collins et al. prepared the first 
load-bearing silk/CaP scaffold via an integrated 
procedure [16]. The generated scaffold presented 
mechanical properties comparable with 
cancellous bone, and a pore size range between 
50 and 100 mm. In another interesting work, 
Zhang et al. tried to improve distribution 
homogeneity of the CaP particle in the scaffold 
by using the silk/CaP hybrid particle instead of 
the pure CaP particle [17]. Actually, it was shown 
that the CaP/silk composite scaffold enhanced 
the osteogenic differentiation of human bone 
mesenchymal stromal cells and promoted the 
cancellous bone formation in calvarial defect in 
SCID mice. However, the compressive strength 
of the scaffolds was less than 80 kPa. The 
above-mentioned studies somehow solved one or 
more challenges in the preparation of silk/CaP 
scaffolds, but had not yet reached the ideal level.
Aim: The development of novel silk/nano-sized calcium phosphate (silk/nano-CaP) scaffolds with highly 
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Nano-CaP was incorporated in a concentrated aqueous SF solution (16 wt.%) by using an in situ synthesis 
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inferior to 200 nm when theoretical CaP/silk ratios were between 4 and 16 wt.%, as determined by scanning 
electron microscopy. The CaP particles displayed a uniform distribution in the scaffolds at both microscopic 
and macroscopic scales as observed by backscattered scanning electron microscopy and micro-computed 
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cytotoxicity confirmed by in vitro bioactivity tests and cell viability assays, respectively. Conclusion: These 
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engineering applications.
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In a previous study, we have developed 
porous SF scaffolds with superior mechanical 
properties by using highly concentrated aqueous 
SF solution, via salt-leaching/freeze-drying 
methods [18]. In this study, we aim to solve the 
above-mentioned challenges by the introduction 
of nano-sized CaP in SF via an in situ synthesis 
method, followed by preparation of the porous 
scaffolds through salt-leaching/freeze-drying 
approaches. The structural conformations of SF 
and CaP were investigated by Fourier transform 
infra-red spectroscopy (FTIR) and/or x-ray 
diffraction (XRD) analysis. The morphology and 
microstructure of the silk/nano-CaP scaffolds 
were evaluated by scanning electron microscopy 
(SEM) and micro-computed tomography 
(micro-CT). The CaP content and Ca/P ratio 
in the scaffold were determined by thermal 
gravimetric analysis (TGA) and energy dispersive 
x-ray detector (EDX), respectively. The size and 
the microscopic distribution of the CaP nano-
particles were also investigated by backscattered 
SEM. The macroscopic distribution of the CaP 
nanoparticles in the scaffold was analyzed 
by micro-CT. The mechanical properties in 
dry state and wet state were characterized by 
compressive tests and dynamic mechanical 
analysis (DMA) at pH 7.4 and 37ºC, 
respectively. Additionally, the hydration degree 
was registered from 3 h up to 30 days, and the 
weight loss was recorded from 1 up to 30 days. 
Finally, the cytotoxicity of the silk/nano-CaP 
scaffolds, along with the silk control scaffolds, 
were evaluated by carrying out a cellular viability 
test (by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophynyl)-2H-
tetr-azolium) assay [MTS]) using mouse lung 
fibroblasts (L929 cell line) cells, which were 
previously in contact with the scaffolds’ extract 
fluids.
Materials & methods
n Materials
Cocoons of B. mori were offered by the 
Portuguese Association of Parents and Friends 
of Mentally Disabled Citizens (APPACDM, 
Portugal). In this study, sodium chloride 
particles (Portugal) of commercial grade were 
used. Silicone tubing (9 mm inner diameter) was 
obtained from Deltalab (Barcelona, Spain). The 
other materials and reagents were supplied by 
Sigma-Aldrich (MO, USA) unless mentioned 
otherwise.
n Preparation of high-concentration 
SF aqueous solution
B. mori SF was extracted from cocoons as 
reported previously with slight modifications 
[12]. Brief ly, the sericin was eliminated by 
boiling the cocoons for 1 h in 0.02 M sodium 
carbonate solution, and then rinsing thoroughly 
with distilled water. The purif ied SF was 
dissolved in 9.3 M lithium bromide solution at 
70°C for 1 h. Following this, the SF solution 
was dialyzed against distilled water by using a 
benzoylated dialysis tubing (MWCO: 2000) for 
a period of 2 days. Afterwards, the SF solution 
was concentrated by dialysis in a 20 wt.% 
poly(ethylene glycol) solution (20,000 g/mol) for 
6 h [19]. Finally, the tubing was carefully rinsed 
in distilled water, and the concentrated solution 
was collected. The concentration of the final 
SF solution was calculated by dividing the dry 
weight by the initial weight of the SF solution. 
The concentrated SF solution was kept at 4°C 
before use.
n Preparation of salt-leached  
silk/nano-CaP scaffolds
Silk/nano-CaP composite was prepared via an 
in situ synthesis method. At first, the concentrated 
SF aqueous solution was diluted to 16 wt.%. 
Different amounts of a calcium chloride solution 
(6 mol/l) were mixed with the SF solution, 
followed by the addition of different amounts 
of an ammonia dibasic phosphate solution (3.6 
mol/l). The theoretical calcium to phosphate 
atomic ratio was maintained at 1.67 in each group. 
The pH value of the system was adjusted to 8.5 by 
the addition of ammonia (30%). The suspension 
was stirred for 30 min and subsequently aged 
for 24 h at room temperature. The theoretical 
content of the CaP formed in the SF solution 
was determined based on the hypothesis that 
the calcium and phosphate species would react 
completely to form stoichiometric HA (HA), 
Ca
10
(PO)
6
(OH)
2
. Silk/nano-CaP composites 
possessing a theoretical CaP content (theoretical 
CaP mass divided by the total mass of SF) of 
4, 8, 16 and 25 wt.% were prepared. Fractions 
of sodium chloride particles having a size in 
the range of 500–1000 mm were obtained by 
using an analytical sieve shaker (Retsch, Haan, 
Germany). The silk/nano-CaP scaffolds were 
prepared by addition of 2.0 g of sodium chloride 
granule (500–1000 µm) to 1 ml silk/nano-CaP 
suspension, in a silicone tubing of 9 mm inner 
diameter, followed by drying the material inside 
the silicone tubing at room temperature for 
2 days. Sodium chloride and the by-products 
were removed by immersion in distilled water for 
2 days. The skin of the silk/nano-CaP scaffolds 
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was removed by a stainless steel punch of 6 mm 
inner diameter. Finally, the scaffolds were frozen 
at -80°C followed by lyophilization in a freeze-
drier (Telstar/Cryodos/80, Terrassa, Spain). 
The prepared silk/nano-CaP scaffolds were 
designated as silk/CaP-4, silk/CaP-8, silk/CaP-
16 and silk/CaP-25, according to their initially 
incorporated amount of CaP, respectively (Figure 
1). The SF scaffolds (control) without CaP were 
also prepared from a 16 wt.% aqueous solution 
following our previously reported method [18].
n Characterization of the 
physicochemical properties
XRD
The crystallinity of the silk/nano-CaP 
scaffolds on powder was investigated using 
an x-ray diffractometer (Philips PW 1710, 
The Netherlands) with Cu-Ka radiation 
(l = 0.154056 nm). Data was collected from 
0 to 60° 2q values, and the step width and 
counting time were set at 0.02° and 2 s per step, 
respectively. The analysis was repeated twice for 
each formulation.
FTIR
The silk/nano-CaP scaffolds were first reduced 
to powder by using a mortar. The powders 
were mixed with potassium bromide (1:100, 
wt%) and then uniaxially pressed to obtain a 
transparent disk. The infrared spectra were 
obtained by FTIR (Perkin-Elmer 1600 series 
equipment, MA, USA), between 4000 to 
500 cm-1. Spectra were recorded at a resolution 
of 4 cm-1 with 32 scans. Each formulation was 
screened three times.
SEM
The cross-sectional morphology of the control 
scaffold and silk/nano-CaP scaffolds were 
observed under SEM (NanoSEM-FEI Nova 
200, OR, USA). Prior to the analysis, the 
specimens were coated with Au/Pd SC502-314B 
in a high vacuum evaporator coater (E 6700, 
Quorum/Polaron, East Grinstead, UK). The 
size and the microscopic distribution of the 
CaP particle in the silk/nano-CaP scaffolds 
were determined. For the purpose of this 
study, silk/nano-CaP scaffolds were milled 
into powder followed by observation of the 
CaP particles in the composite powder via 
backscattered SEM (NanoSEM-FEI Nova 200) 
without any coating. The calcium and phosphate 
content in the powder was investigated by EDX 
during the SEM observation.
CaP content & Ca/P atomic ratio in the 
silk/nano-CaP scaffolds
The CaP content in the silk/nano-CaP scaffolds 
was determined by TGA (TGA Q500, TA 
Instruments, DE, USA). Each specimen was 
placed in a platinum pan and equilibrated at 
50°C for 2 min, followed by increasing the 
temperature to 700°C at a rate of 20ºC/min in 
Figure 1. Macroscopic images of the silk/nano-sized calcium phosphate scaffolds.  
(A) Silk/CaP-4, (B) silk/CaP-8, (C) silk/CaP-16 and (d) silk/CaP-25. Scale bar: 3 mm.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/
nano-CaP scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk 
fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP 
scaffold with 25 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin).
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air atmosphere. The CaP content in the scaffolds 
(CaP mass divided by the mass of SF) and the 
CaP incorporation efficiency were determined 
using equations 1 & 2, respectively:
CaP content = [m
r
/(m
i
 – m
r
)] × 100% 
(equation 1)
CaP incorporation efficiency = (CaP content/
theoretical CaP content) × 100%
(equation 2)
The m
r
 is the weight of the residual, and the 
m
i 
is the initial weight of the scaffolds. The 
theoretical contents for silk/CaP-4, silk/CaP-8, 
silk/CaP-16 and silk/CaP-25 are 4, 8, 16 and 
25 wt.%, respectively. Three specimens were 
evaluated for each formulation.
For the determination of the Ca/P atomic 
ratio in the scaffold, the silk/nano-CaP scaffolds 
were burned at 700ºC for 40 min in a furnace 
(Fornoceramica, Leiria, Portugal) to remove the 
SF. The obtained residual CaP was adhered in 
a cooper support for the analysis of the Ca/P 
atomic ratio by EDX (NanoSEM-FEI Nova 
200). In each condition, f ive independent 
areas (200 × 200 µm) of the residual CaP were 
selected.
Micro-CT
The microstructure of the silk/nano-CaP 
scaffolds was qualitatively and quantitatively 
investigated by employing a high-resolution 
µ-CT (1072 scanner, SkyScan, Kontich, 
Belgium) possessing a resolution of pixel size of 
~6.7 µm and time of integration of 1.3 s. The 
x-ray source was fixed at 61 keV and 163 µA. 
Around 300 projections were obtained over 
a 180º rotation with a step width of 0.45º. 
Data sets were rebuilt employing standardized 
software (NRecon v1.4.3, SkyScan) in a cone-
beam model. The format of the output for each 
specimen was 300 serial bitmap images with 
1024 × 1024 pixels. Representative serial images 
in each dataset were transferred into binary 
images by using grey values (dynamic threshold) 
of 40–255. Finally, the binary images were used 
for microstructrual analysis (CT Analyser, 
version 1.5.1.5, SkyScan), and to establish the 
3D models (ANT 3D creator, version 2.4, 
SkyScan). At least three specimens were used for 
each condition. The macroscopic distribution 
of CaP in the silk/nano-CaP scaffolds was also 
assessed by micro-CT. The test followed the 
same procedure as mentioned above, but the 
dynamic threshold was set between 120 and 
255 (grey values).
Mechanical properties
Compressive tests (dry state)
The tests were conducted in an unconfined 
mode by using a Universal Testing Machine 
(Instron 4505) with a load cell of 1 kN and 
at ambient temperature. The height and the 
diameter of the tested specimens were measured 
by a micrometer. The length and diameter of the 
tested specimens were approximately 6.50 mm 
and 5.30 mm, respectively. The cross-head 
speed was fixed at 2 mm/min and until 60% 
deformation in specimen height. The elastic 
modulus (E) was obtained from the slope of the 
initial linear domain of the stress–strain curve. 
The compressive strength was determined when 
the scaffold crushed. At least seven specimens for 
each formulation were tested.
DMA (wet state)
The viscoelastic mechanical properties of the 
scaffolds were measured by TRITEC8000B 
DMA (Triton Technology, UK) in a compressive 
mode. Scaffolds (cylindrical shape with 6 mm 
diameter and 4 mm thickness) were kept in a 
phosphate-buffered saline solution (PBS) at 
37°C overnight. Afterwards, the specimens were 
fixed in the DMA apparatus and kept immersed 
in the PBS solution during the measurement. 
After reaching the equilibrium at 37ºC, the 
DMA spectra were recorded during a frequency 
sweep, ranging from 0.1 up to 25 Hz. Constant 
strain amplitude of 50 µm was used in all the 
experiments. Before the test, a small amount of 
preload was applied to each specimen to allow the 
complete contact of the scaffold surface with the 
compression plates. The distance between the 
plates was the same for all the tested scaffolds. 
A minimum of four samples was used for each 
formulation.
Hydration degree & weight loss ratio
The hydration degree (time period: 3 h until 
30 days) and degradation behavior (time period: 
1 to 30 days) of the silk/nano-CaP scaffolds 
were assessed after immersion into an 0.154 M 
sodium chloride isotonic saline solution (ISS, 
pH 7.4) [18]. These experiments were conducted 
at 37°C and dynamic condition (60 rpm) in a 
water bath (GFL 1086). At the end of each time 
point, the specimen was removed from the ISS 
and the wet weight was measured immediately 
after removing the excess surface water by 
using a filter paper. The hydration degree was 
calculated using equation 3:
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Hydration degree = [(m
w, t
 - m
0
)/m
0
] × 100%
(equation 3)
where m
0
 is the initial weight of the sample 
before hydration, and m
w, t
 is the wet weight of 
the sample at time t after being removed from 
the ISS.
After the determination of the hydration 
degree, the specimens were rinsed with distilled 
water several times and dried in an oven at 60ºC 
for 24 h. The weight loss ratio was determined 
using equation 4:
Weight loss ratio = [(m
0
 - m
d, t
)/m
0
] × 100%
(equation 4)
where m
d, t
 is the dry weight of the specimen 
being immersed in ISS for a certain time, and 
after drying at 60ºC for 24 h. Five specimens 
were measured for each formulation.
In vitro mineralization
The silk/nano-CaP scaffolds were immersed in 
a simulated body fluid (SBF) [20] solution for 
7 days in an oven at 37°C, following the method 
proposed by Kokubo et al. and adapted by Oliveira 
et al. [20,21]. At each timepoint, the specimens 
were removed from the SBF and washed by 
distilled water. The samples were frozen at -80ºC 
and lyophilized (Telstar/Cryodos/80, Spain). 
Then, the surfaces of the samples were analyzed 
by SEM and EDX (NanoSEM-FEI Nova 200). 
Prior to the SEM and EDX analysis, the samples 
were coated with carbon in a high vacuum 
evaporator coater (E 6700, Quorum/Polaron). 
For the EDX analysis, the data were collected 
by scanning three independent areas (5 × 5 µm) 
in each specimen for 90 s. Three specimens 
were analyzed in each assay for each group of 
scaffolds.
In vitro cytotoxicity screening
A 3 - (4,5 -d imethylth ia zol-2-y l ) -5 - (3 -
carboxymethoxyphenyl)-2-(4-sulfophynyl)-
2H-tetrazolium) (MTS) assay was performed to 
evaluate cytotoxicity of the silk/CaP-16 and silk 
control scaffold in comparison to latex (positive 
control for cell death), in accordance with 
ISO/EN 10993 (1992) Part 5 guidelines. Mouse 
lung fibroblasts (L929 cell line) were cultured 
as a monolayer in a Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS, Biochrom, Berlin, 
Germany), 1% of antibiotic–antimycotic 
mixture (Invitrogen, USA) containing 
10,000 U/ml penicillin G sodium, 10 mg/ml 
streptomycin sulfate and 25 µg/ml amphotericin 
B as Fungizone® (E.R. Squibb & Sons, NJ, USA) 
antimycotic in 0.85% saline. The L929 cells 
were incubated in an atmosphere containing 
5% CO
2
 at 37°C, with the medium changed 
every 2 days.
The extract fluids were prepared as previously 
reported by Oliveira et al. [21]. Briefly, extract 
f luids were obtained by immersing 1 g of 
scaffolds (sterilized by autoclave) in 50 ml tubes 
containing 20 ml complete DMEM culture 
medium. The tubes were incubated in a water 
bath at 37°C and 60 rpm for 24 h. A latex 
rubber extract was used as a positive control. 
Afterwards, the extract fluids were filtrated by 
using a 0.45 µm filter. Confluent L929 cells were 
detached from the culture flasks using trypsin 
(0.25% trypsin–EDTA solution) and a diluted 
cell suspension was prepared. The cells were 
seeded in a 96-well tissue culture polystyrene 
(TCPS) plate (six replicates per sample) at a cell 
density of 20,000 cells/well and incubated for 
24 h at 37°C in an atmosphere with 5% CO
2
. 
The culture medium in each well was removed 
and replaced by an identical volume (200 ml) of 
the extraction fluids. Cell culture medium was 
used as negative control. After 1, 3 and 7 days, 
the extracts were removed and replaced by 
300 µl of mixed solution containing serum-free 
culture medium (without phenol red) and MTS 
(CellTiter 96 One Solution Cell Proliferation 
Assay Kit, Promega, PA, USA). After incubation 
for 3 h at 37°C in an atmosphere with 5% 
CO
2
, the optical density (OD) was measured 
at 490 nm using a plate reader (Molecular 
Devices, CA, USA). Cell viability was calculated 
by subtracting the mean OD value of the blank 
(MTS solution) from the ones of the scaffolds 
and controls, followed by normalization with 
the mean OD value obtained for the negative 
control (cell culture medium). The MTS assay 
was performed in triplicate (n = 18).
n Statistical analysis
All data were presented as average and standard 
deviation. A one-way analysis of variance 
(ANOVA) was used to assess the data obtained 
from TGA analysis, micro-CT analysis, 
compressive tests and cytotoxicity test. The 
comparison between two average values was 
evaluated using Tukey’s test with p < 0.05 as 
statistical significance.
Results
n Chemical structure
Figure 2a shows the XRD patterns of the silk 
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and silk/nano-CaP porous scaffolds. The 
characteristic peaks of silk-II structure located at 
9.0° and 20.5° were detected for all the scaffolds 
[12,19]. The broad peak width and low intensity 
of these two peaks indicate that the SF was 
of low crystallinity, comprising an uncertain 
amount of random coil. It was observed that as 
the amount of incorporated CaP increased, the 
intensity of the peaks located at 25.9°, 32.1° and 
39.7° slightly increased. These peaks indicate 
that the CaP incorporated in the scaffold is a 
HA presenting low crystallinity [22]. The FTIR 
spectra (Figure 2B) corroborated the XRD analysis 
that revealed the conformation of silk-II in the 
SF in all the scaffolds. Peaks located at 1704 cm-1 
and 1622 cm-1 can be attributed to silk-II [23,24]. 
The absorption area attributed to the v3
 
vibration 
of the PO
4
3- bond (between the absorption range 
of 970 cm -1 and 1100 cm-1) increased with the 
increasing CaP content [17,21,25]. The v4
 
vibration 
of the PO
4
3- bond located at 607 cm-1 and 
560 cm-1 [17,21,25] was distinct in the spectrum 
of silk/CaP-25, while the spectra of silk/CaP-4, 
silk/CaP-8 and silk/CaP-16 presented a lower 
intensity for this absorption. The XRD and 
FTIR results demonstrated that the CaP 
particles were successfully generated within the 
scaffolds.
n Morphology & microstructure
Figure 3 shows SEM images of the different silk/
nano-CaP scaffolds. All the scaffolds presented 
a macro/micro porous structure. The size 
of the macro-pores is around 500 µm, and 
highly interconnected (Figure 3a, D, g & J). The 
trabeculae of the macro-pores were composed 
of partially interconnected micro-pores with a 
size ranging from 10 to 100 µm (Figure 3B, e, H 
& K). An interesting finding is the formation of 
cauliflower-like apatite clusters on the surface of 
silk/CaP-25, with a size around 700 nm (Figure 3L, 
inserted image). The clusters are composed of 
flake-like and worm-like apatite crystal.
The microstructure of the control and the 
silk/nano-CaP scaffolds was qualitatively and 
quantitatively studied by micro-CT (Figures 4 & 5). 
A highly porous structure was observed in all 
the silk/nano-CaP scaffolds from the two-
dimensional and three-dimensional micro-CT 
images (Figure 4). From the three-dimensional 
micro-CT images, it is also possible to observe 
that the macro-pores are interconnected. 
Silk/CaP-4 possessed the highest porosity in 
the trabeculae of the macro-pores as compared 
with the other groups (Figure 4a–D). The two-
dimensional micro-CT images also confirmed 
this observation (Figure 4e–H). Figure 5a shows that 
silk/CaP-4 presented the highest mean porosity 
(77.61 ± 0.72%), while silk/CaP-16 exhibited 
the lowest one (63.56 ± 2.43%) among the 
silk/nano-CaP scaffolds. The representative 
porosity distribution profile (Figure 5B) shows 
that a homogeneous porosity was observed for 
all the scaffolds. Figure 5C demonstrates that 
all the scaffolds presented interconnectivities 
higher than 70%. Silk/CaP-4 and silk/CaP-8 
presented higher interconnectivity as compared 
to silk/CaP-16 and silk/CaP-25. The control 
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Figure 2. X-ray diffraction patterns (A) and Fourier transform infra-red spectroscopy 
spectra (B) of the silk and silk/nano-CaP scaffolds. (1) Control, (2) silk/CaP-4; (3) silk/CaP-8; 
(4) silk/CaP-16; (5) silk/CaP-25.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate. initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-4: Silk/nano-CaP scaffold 
with 8 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: 
Silk/nano-CaP scaffold with 8 wt.% initially theoretically incorporated CaP (divided by the mass of 
silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin).
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possessed higher porosity and interconnectivity 
as compared to all the silk/nano-CaP scaffolds.
n Characterization of the CaP in the 
scaffold
taBLe 1 shows the CaP content and the 
incorporation eff iciency for the different 
silk/nano-CaP scaffolds. After the extraction of 
sodium chloride particles, the CaP content was 
measured by TGA. This result demonstrated 
that most of the CaP formed was retained in 
the silk/CaP-8 and silk/CaP-16 as compared 
to silk/CaP-4 and silk/CaP-25. The Ca/P 
atomic ratio determined by EDX analysis is 
also shown in taBLe 1. The Ca/P atomic ratio 
was approximately 1.67 for all the silk/nano-
CaP scaffolds, indicating the CaP synthesized in 
SF is similar to HA with respect to its chemical 
composition.
The backscattered SEM was used to identify 
the CaP particles and observe their microscopic 
distribution in the silk/nano-CaP composite 
powder based on the contrast differences of 
each element. EDX was employed to confirm 
the presence of the CaP particles together 
with backscattered SEM. The amount of CaP 
particles (white regions) in the composite 
powder increased when increasing the amount 
of initially incorporated CaP in the SF (Figure 
6a–H). The size of the CaP particles in silk/CaP-
4, silk/CaP-8 and silk/CaP-16 was inferior to 
200 nm. Despite this, it was possible to observe 
particles with a size close to 1 µm in silk/CaP-
25. The distribution of the CaP particles in 
silk/CaP-8, silk/CaP-16 and silk/CaP-25 was 
uniform at a microscopic scale (Figure 6C–H). 
The EDX spectra (Figure 6i–L) also showed that 
the CaP particles observed in the silk/nano-CaP 
scaffolds were generated without any by-product 
present – i.e., no chloride (from ammonia 
chloride and sodium chloride) and sodium ions 
(from sodium chloride) were detected. The CaP 
particles were well integrated into the SF matrix 
(Figure 6M & n).
Micro-CT analysis was performed in order 
to determine the distribution of CaP particles 
in the different silk/nano-CaP scaffolds. The 
sole CaP distribution profile (Figure 7a) shows 
that the CaP content (vol. %) increased from 
silk/CaP-4 to silk/CaP-16, and the distribution 
of CaP in the silk/nano-CaP scaffolds was 
homogeneous in each group. The combined 
SF and CaP distribution profile (Figure 7B) 
revealed that CaP content increased from silk/
CaP-4 to silk/CaP-16, and the CaP presented 
homogeneous distribution at a macroscopic 
scale.
nMechanical properties
Figure 8 shows the compressive mechanical 
properties of the control and different silk/nano-
CaP scaffolds determined in dry conditions. The 
values of the compressive modulus (Figure 8a) were 
15.14 ± 1.70 MPa, 16.76 ± 4.58 MPa, 13.75 ± 2.99 
MPa, 19.02 ± 5.77 MPa and 4.87 ± 0.95 MPa for 
the control, silk/CaP-4, silk/CaP-8, silk/CaP-
16 and silk/CaP-25, respectively. The values 
of the compressive strength (Figure 8B) were 
I
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Figure 3. Morphology of the silk/nano-sized calcium phosphate scaffolds 
determined by scanning electron microscopy. (A), (d), (G) and (J): overview 
of silk/CaP-4, silk/CaP-8, silk/CaP-16 and silk/CaP-25, respectively (scale bar: 
500 μm); (B), (e), (H) and (K): trabecular structure of silk/CaP-4, silk/CaP-8, silk/
CaP-16 and silk/CaP-25, respectively (scale bar: 100 μm); (C), (F), (I) and (L): 
surface of the micro-pores of silk/CaP-4, silk/CaP-8, silk/CaP-16 and silk/CaP-25, 
respectively (scale bar: 5 μm). The inserted image in (L) is the amplified image of 
(L), scale bar: 500 nm.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium 
phosphate; silk/CaP-4: Silk/nano-CaP scaffold with 4 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP 
scaffold with 8 wt.% initially theoretically incorporated CaP (divided by the mass of 
silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP 
scaffold with 25 wt.% initially theoretically incorporated CaP (divided by the mass 
of silk fibroin). 
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0.69 ± 0.12 MPa, 0.59 ± 0.14 MPa, 0.63 ± 0.11 
MPa, 0.62 ± 0.11 MPa and 0.25 ± 0.03 MPa for 
the control, silk/CaP-4, silk/CaP-8, silk/CaP-
16 and silk/CaP-25, respectively. Regarding the 
compressive modulus and strength, there were 
no significant differences among the control, 
silk/CaP-4, silk/CaP-8 and silk/CaP-16.
The dynamic mechanical properties (wet 
conditions) of the control and different 
silk/nano-CaP scaffolds were also assessed by 
DMA (Figure 9). The storage modulus (E’ ) of silk/
CaP-4, silk/CaP-8 and silk/CaP-16 increased with 
the increasing of tested frequency (from 0.1 Hz to 
25 Hz), while the E’ for silk/CaP-25 presented no 
significant differences in all the tested frequencies. 
When the CaP content increased from 4% up to 
16%, the storage modulus also increased for all 
the tested frequencies. Silk/CaP-16 presented the 
highest value in respect to storage modulus, which 
varied from 0.53 ± 0.15 MPa to 0.87 ± 0.12 MPa 
when the frequency increased from 0.1 Hz to 25 
Hz. The loss factor (tan d) of silk/CaP-4, silk/
CaP-8 and silk/CaP-16 were comprised between 
0.16 and 0.2 when the tested frequency was 
inferior to 10 Hz.
n Hydration degree & weight loss ratio
Figure 10 shows the hydration degree and weight 
loss ratio for the control and several silk/nano-
CaP scaffolds. The hydration degree of each 
group scaffolds was maintained after immersion 
in sodium chloride solution after 6 h (Figure 10a). 
When increasing CaP content from 4 wt.% 
up to 16 wt.%, the hydration degree of the 
silk/nano-CaP scaffolds decreased after 6 h 
immersion. The hydration degree behavior of 
silk/CaP-25 was similar to silk/CaP-16 and the 
control. Regarding the weight loss profile, silk/
CaP-4 presented the lowest weight loss ratio as 
compared to the other silk/nano-CaP scaffolds 
at day 1 and day 3 (Figure 10B). After 7 days of 
soaking, the weight loss value of all the silk/
nano-CaP scaffolds presented no significant 
differences, while the control group presented 
Figure 4. Micro-computed tomography three-dimensional images of (A) silk/CaP-4,  
(B) silk/CaP-8, (C) silk/CaP-16, and (d) silk/CaP-25silk scaffolds and respective two-
dimensional images (e, F, G & H). Scale bar: 3 mm.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/
nano-CaP scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk 
fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP 
scaffold with 25 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin).
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lower weight loss profile as compared with all 
the silk/nano-CaP scaffolds after immersion for 
7 days.
n In vitro mineralization
After immersion of the silk/nano-CaP scaffolds 
in SBF solution for 7 days, mineralized nuclei 
had grown on the surface of all the silk/nano-
CaP scaffolds, as shown in Figure 11a–D. The 
EDX spectra confirmed that no other species 
than calcium and phosphorus have mineralized 
on the surface of the scaffolds (Figure 11e–H). The 
intensity of calcium and phosphorus signals 
increased from silk/CaP-4 to silk/CaP-25 (Figure 
11e–H). Since EDX can detect elemental content 
under the surface up to 2 µm, the nano-CaP 
from the scaffolds might also contribute to 
the detected calcium and phosphorus signals. 
Further quantification analysis of the CaP 
minerals formed on the surface of the scaffolds 
should then be performed. The apatite minerals 
exhibited worm-like or flake-like morphology, 
with a size less than 500 nm (Figure 11a–D). It 
was also found that the minerals grew into 
cauliflower-like clusters, which were dominant 
in silk/CaP-25. This typical morphology has 
been described in previous studies [26], and 
results from the ability of a surface to induce per 
se the nucleation and growth of an apatite layer.
n Cytotoxicity assessment
Latex leachables was used as control for cell 
death (positive control) in this study. This 
material has been described as cytotoxic and it 
has long been used [21] as control of cell death, 
in standard cytotoxicity assays. Figure 12 shows 
the cytotoxicity results of the silk control and 
silk/CaP-16. Cell viability of the silk control 
increased from day 1 to day 3 (p < 0.05), without 
significant difference between day 3 and day 7. 
Cell viability of silk/CaP-16 seemed to increase 
from day 1 to day 3, but without significant 
statistical difference. At day 7, silk/CaP-16 
presented higher cell viability as compared 
to values obtained at day 1 and day 3, and as 
well as those of the silk control at all the tested 
time points. Furthermore, both silk control 
and silk/CaP-16 showed higher cell viability as 
compared to the negative control at day 3 and 
day 7. The positive control (latex) presented 
negative values in cell viability at all the tested 
time points (p < 0.05). The negative value (%) 
of the positive control was due to the OD value 
of the latex being lower than the one of the blank 
(MTS); thus, it would generate a negative value 
following the calculation procedure (see section 
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Figure 5. (A) Mean porosity, (B) representative porosity distribution along 
the length, and (C) interconnectivity of the silk/nano-sized calcium 
phosphate porous scaffolds determined by micro-computed tomography. 
(A) †indicates significant differences compared with silk/CaP-4, silk/CaP-8, silk/CaP-
16 and silk/CaP-25; ‡indicates significant differences compared with silk/CaP-8, silk/
CaP-16 and silk/CaP-25; §indicates significant differences compared with silk/CaP-16. 
(C) †indicates significant differences compared with silk/CaP-4, silk/CaP-8, silk/CaP-
16 and silk/CaP-25; ‡indicates significant differences compared with silk/CaP-8 and 
silk/CaP-16; §indicates significant differences compared with silk/CaP-16. 
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; 
silk/CaP-4: Silk/nano-CaP scaffold with 4 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-
16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin).
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‘In vitro cytotoxicity screening’ in Materials and 
Methods).
discussion
In previous studies, porous silk/CaP scaffolds 
have shown promising potential in bone tissue 
engineering scaffolding [14–17,27]. However, 
a silk/CaP scaffold possessing suitable 
mechanical properties, proper microstructure 
and homogeneous distribution of the CaP 
particles to better match bone tissue engineering 
scaffolding demand has not yet been developed. 
Previously, macro-/micro-porous silk scaffolds 
with good mechanical properties and high 
interconnectivity were developed by means of 
using high-concentration aqueous SF solution 
(up to 16 wt.%) and a combination of salt-
leaching/lyophilization approaches [18]. In the 
present study, we propose an in situ synthesis 
method for the formation of nano-sized CaP 
particles within the matrix of macro/micro 
porous SF scaffolds.
Figure 2 showed that the CaP particles 
were successfully incorporated in the SF 
scaffolds. The XRD analysis indicated that the 
incorporated CaP particles could be assigned 
to a low crystalline HA, which is of great 
biomedical relevance as it can mimic closer bone 
apatite [23]. Dorozhkin reported that mixing 
the calcium and phosphate ions in aqueous 
solution would first form amorphous calcium 
phosphates, which were thermodynamically 
unstable compounds and spontaneously tended 
to transform into crystalline apatite [23]. In the 
present work, the CaP particles (amorphous 
CaP) were aged in the SF solution for 24 h (HA) 
prior to their incorporation into the SF scaffold. 
The XRD results show that the CaP did not 
change its structure during the salt-leaching in 
distilled water for 2 days. This result is consistent 
with the previous study [28], which studied the 
SF-regulated mineralization process of calcium 
phosphate. The XRD and FTIR results also 
indicate that the incorporation of CaP did not 
impair the formation of b-sheet conformation in 
the SF. The formation of b-sheet is critical for 
the maintenance of the mechanical properties 
and structural stability of the silk/nano-CaP 
scaffolds.
Kim et al. found that the addition of sodium 
chloride particles into SF solution would induce 
the formation of b-sheet conformation in the 
SF [12]. Based on this finding, they were able to 
generate aqueous-derived porous SF scaffolds. 
However, with this method, they only prepared 
SF scaffolds using aqueous SF solution with no 
Table 1. The calcium phosphate content, calcium phosphate incorporation 
efficiency and calcium/phosphate atomic ratio in the silk/nano-sized calcium 
phosphate scaffolds determined by thermal gravimetric and energy dispersive 
x-ray detector analyses.
Groups Theoretical CaP 
content (wt%)†
Final CaP content 
(wt%)‡
CaP incorporation 
efficiency (%)§
Ca/P atomic 
ratio¶ 
Silk/CaP-4 4 2.57 ± 0.04 64.17 ± 0.88 1.66 ± 0.06
Silk/CaP-8 8 6.92 ± 0.35# 86.44 ± 4.44 1.68 ± 0.06
Silk/CaP-16 16 13.92 ± 0.76†† 87.01 ± 4.72 1.67 ± 0.05
Silk/CaP-25 25 18.16 ± 1.00‡‡ 72.63 ± 4.01 1.65 ± 0.03
†The theoretical CaP content was calculated based on the hypothesis that the added Ca and P ions would react completely 
and that the formed CaP would be Ca
10
(PO)
6
(OH)
2
 (hydroxyapatite), which is the most stable phase under the processing 
conditions. The values were obtained by dividing the mass of the theoretical formed CaP by the mass of silk fibroin in each 
condition. 
‡The final CaP content is determined by dividing the mass of residual CaP obtained from thermal gravimetric assay by the 
mass of silk fibroin (determined by total mass of the scaffold minus the mass of residual CaP). 
§The CaP incorporation efficiency was calculated by dividing the final CaP content by the theoretical CaP content. 
¶The Ca/P atomic ratio was determined by analysis of the CaP residual by energy dispersive x-ray detector analysis after 
burning the scaffolds in a furnace. In each condition, five independent areas (200 × 200 µm) of the CaP residual were 
selected for this assay. 
#Significant difference compared with silk/CaP-4. 
††Significant differences compared with silk/CaP-4 and silk/CaP-8. 
‡‡Significant differences compared with silk/CaP-4, silk/CaP-8 and silk/CaP-16. 
CaP: Calcium phosphate; Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: 
Silk/nano-CaP scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: 
Silk/nano-CaP scaffold with 8 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: 
Silk/nano-CaP scaffold with 16 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-
25: silk/nano-CaP scaffold with 25 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin).
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more than 10 wt.% concentration. In our recent 
study, it was shown that SF scaffold obtained 
combining salt-leaching and lyophilization 
methods can be prepared by using aqueous SF 
solution up to 16 wt.% [18]. In the present study, 
we demonstrated that the salt-leached porous 
silk/nano-CaP scaffolds derived from 16 wt.% 
SF aqueous solution can also be prepared by a 
similar approach (Figures 1 & 3). The SEM analysis 
of the silk/nano-CaP scaffolds revealed that 
the morphology of the silk/CaP-4, silk/CaP-8 
and silk/CaP-16 was similar to that of pure SF 
scaffold (16 wt.%) [18]. The formation of the 
apatite crystals on the surface of silk/CaP-25 can 
occur during the extraction procedure. During 
the salt extraction, the CaP particles would 
partially dissolve in water, increasing the local 
concentration of calcium and phosphate ions. 
The local enrichment of calcium and phosphate 
ions was favorable for the nucleation of apatite on 
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Figure 6. distribution and particle size of the calcium phosphate particle in the silk/nano-sized calcium phosphate scaffolds 
determined by scanning electron microscopy and energy dispersive x-ray detector analysis. (A–H) were observed in a 
backscattered scanning electron microscopy (SEM) model, while (M) and (N) were observed in a secondary electron SEM model.  
(A), (C), (e) and (G): SEM images for silk/CaP-4, silk/CaP-8, silk/CaP-16 and silk/CaP-25, respectively (scale bar: 5 μm). (B), (d), (F) and 
(H): amplified SEM images of (A), (C), (e) and (G), respectively (scale bar: 1 μm). (M) and (N): secondary electron SEM images of (d) 
and (F), respectively (scale bar: 1 μm). (I), (J), (K) and (L): Energy dispersive x-ray detector spectra of (B), (d), (F) and (H), respectively. 
CaP: Calcium phosphate; silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/nano-CaP 
scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 
8 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin).
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the surface of the scaffolds, similar to the process 
observed for the studies on the biomineralization 
of HA scaffolds in a stimulated body fluid [21]. 
The size of the macro-pores (around 500 mm) 
in all the silk/nano-CaP scaffolds is adequate 
for bone scaffolding, as it has been shown to 
support new bone formation and vascularization 
[29]. The size of the micro-pores in the silk/nano-
CaP scaffolds is suitable for promoting the cell 
attachment and proliferation [29]. Furthermore, 
the macro-pores are highly interconnected 
(Figure 3), which would benefit cell ingrowth and 
tissue regeneration.
It has been shown that micro-CT is a 
powerful tool to quantitatively and qualitatively 
characterize the microstructure of scaffolds [30]. 
The observation from the three-dimensional 
and two-dimensional micro-CT images 
(Figure 4) corroborates the data obtained from 
the SEM images in respect to the morphology 
of scaffolds (Figure 3). Silk/CaP-4 possessed the 
lowest amount of CaP content as compared with 
the other groups; thus, its porosity (Figure 5a) is 
closest to that of the control [18]. As the initially 
incorporated content of the CaP increased from 
4 wt.% to 16 wt.%, the total porosity of the 
scaffolds decreased (Figure 5). This is because the 
trabeculae of the macro-pores of the scaffolds 
were impregnated with increased CaP particles. 
Actually, this observation is supported by the 
data obtained from micro-CT analysis (Figure 4). 
As the initially incorporated CaP content 
increased up to 25 wt.%, silk/CaP-25 presented 
lower structural integrity compared with other 
groups (Figures 3, 8 & 9), and thus induced a 
higher porosity as compared with silk/CaP-16 
(Figure 5a). Moreover, it was also observed that 
the distribution of the porosity along the scaffold 
is homogenous in all the groups (Figure 5B), and 
the interconnectivity remained at a high level 
(Figure 5C), indicating that the incorporation 
of CaP particles did not affect the foreseen 
architecture of the scaffolds.
The SF retained a large amount of the initially 
incorporated CaP in the scaffolds (taBLe 1) within 
the SF matrix. The highly concentrated SF 
aqueous solution played an important role in 
preventing the leaching out of the CaP particles 
from the scaffolds. In our previous study [18], it 
was found that the thickness of the trabeculae of 
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Figure 7. Three-dimensional images of pure calcium phosphate distribution and calcium phosphate distribution in silk 
fibrion in the silk/nano-sized calcium phosphate porous scaffolds, determined by micro-computed tomography.  
In (B), silk fibroin: the gray domain; CaP: the white domain. (1) and (5): silk/CaP-4; (2) and (6): silk/CaP-8; (3) and (7): silk/CaP-16; (4) 
and (8): silk/CaP-25 (scale bar: 3 mm).  
CaP: Calcium phosphate; silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/nano-CaP 
scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 
8 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin).
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the macro-pores in the salt-leached SF scaffolds 
increase with the increase of SF concentration, 
being higher for scaffolds derived from 16 wt.% 
SF solutions. We observed that the thicker the 
trabeculae thickness, the higher the amount 
of CaP can be retained in the scaffolds (data 
not shown). This justifies the use of a highly 
concentrated SF aqueous solution in this study. 
It should be addressed that the CaP vol.% shown 
in Figure 7, cannot represent the real CaP particle 
content in each group of scaffolds. This is due 
to the fact that the resolution of the micro-CT 
equipment used in this study is 6 mm. Since the 
size of most of the CaP particles is less than 
1 µm, it is impossible to quantitatively determine 
the CaP content in the silk/nano-CaP scaffolds 
by micro-CT. A similar observation has been 
reported in previous studies; Oliveira et al. 
quantified the biomimetic CaP coating by 
micro-CT for the first time [30]. It was found that 
the micro-CT equipment was still capable of 
detecting the CaP coating – even the thickness 
of the biomimetic CaP coating was around 8 mm 
and the resolution of the micro-CT instrument 
was 11 mm, due to the high diffraction of the 
ceramic when comparing with the polymer. 
This observation was consistent with the result 
in this study (Figure 7). On the other hand, 
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Figure 8. (A) Compressive modulus and (B) compressive strength of the silk and silk/nano-
sized calcium phosphate scaffolds. †indicates significant differences compared with silk/CaP-4, 
silk/CaP-8 and silk/CaP-16.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/
nano-CaP scaffold with 4 wt.% initially theoretically incorporated CaP (divided by the mass of silk 
fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially theoretically incorporated CaP 
(divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP 
scaffold with 25 wt.% initially theoretically incorporated CaP (divided by the mass of silk fibroin).
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Bhumiratana et al. also found that not all the 
HA micro-particles were detected by micro-CT, 
since the resolution of micro-CT (21 µm) is a 
little higher than the approximate size of HA 
(20 µm) [27]. That is the reason why we used 
TGA to quantitatively evaluate the CaP content 
of the silk/nano-CaP scaffolds. On the other 
hand, the formed CaP presented a Ca/P atomic 
ratio close to 1.67, which is in good agreement 
with the initial Ca/P atomic ratio (taBLe 1), 
and corresponds to the value calculated for 
stoichiometric HA.
A previous study by Kong et al. has shown 
that the in situ synthesis approach allowed 
for the formation of nano-sized HA crystal 
in the diluted SF solution (less than 2 wt.%) 
[28]. However, with low-concentration SF 
solution, it is difficult to generate a mechanical 
stable porous scaffold [14]. In this study, we 
performed, for the first time, the synthesis of 
nano-sized CaP particles in highly concentrated 
SF solution by an in situ synthesis method. 
Our approach allowed the development of SF 
scaffolds with good mechanical properties and 
generattion of nano-sized CaP particles in the 
scaffold. It was reported that the nano-sized 
particles tend to aggregate and precipitate 
due to the electrostatic interaction [17]. Our 
preliminary result also showed that the CaP 
particles would precipitate at the bottom when 
aqueous SF solutions of low concentration were 
used (data not shown). The backscattered SEM 
images confirmed that the nano-sized CaP 
presented a homogeneous distribution, without 
aggregation, in the SF matrix at a microscopic 
scale (Figure 6). Furthermore, the CaP particles 
were homogeneously distributed in all the 
silk/nano-CaP scaffolds, at a macroscopic scale 
(Figure 7). It can be concluded that the highly 
concentrated SF aqueous solution had prevented 
the aggregation and the precipitation of the 
nano-size CaP particles in the composite system.
A homogeneous distribution of nano-sized 
or micro-sized CaP particles in the SF scaffold 
without aggregation is still very challenging. 
Liu et al. prepared silk/CaP scaffolds by 
physical mixture of SF and nano-sized HA 
particles in aqueous phase [31]. However, there 
was evidence that the nano-sized HA particles 
partially aggregated into micro-sized particles on 
the surface of the macro-pores in the scaffold. 
Bhumiratana et al. produced porous silk/CaP 
scaffolds by physically mixing the SF and micro-
sized HA particles in organic phase [27]. From 
the SEM observations, it was found that the HA 
particles were partially aggregated at the surface 
of the scaffolds. Zhang et al. prepared silk/CaP 
porous scaffold from SF aqueous solution and 
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Figure 9. (A) storage modulus and (B) loss factor of the silk and silk/nano-sized calcium phosphate scaffolds determined by 
dynamic mechanical analysis at 37°C in phosphate-buffered saline solution. 
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/nano-CaP scaffold with 4 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin).
www.futuremedicine.com doi:10.2217/NNM.12.118future science group
Bioactive macro/micro porous silk fibroin/nano-sized calcium phosphate scaffolds ReseaRch aRticle
micro-sized CaP/silk hybrid particles [17]. The 
CaP/silk particles distributed homogenously at 
a macroscopic scale in the scaffold in their study. 
From the above-mentioned studies, it was found 
that it is feasible to achieve a homogeneous 
distribution of the CaP particles in SF scaffolds, 
but not at a microscopic scale. In the present 
study, the combination of an in situ synthesis 
method and highly concentrated SF aqueous 
solution was used to solve this challenge. 
Notably, this combination approach allowed 
the formation of nano-sized CaP particles and 
prevented the aggregation and precipitation of 
the CaP particles (Figure 6a–H). As a consequence, 
it allowed the homogeneous distribution of the 
nano-sized CaP particles in the silk/nano-CaP 
scaffolds, at both microscopic scale (Figure 6C–H) 
and macroscopic scales (Figure 7). The prepared 
silk/nano-CaP scaffolds were shown to comprise 
both homogeneous porosity and CaP particle 
distribution across the scaffolds, which is an 
advantage for tissue engineering scaffolding.
The mechanical performance of a scaffold 
plays an important role in tissue regeneration, 
especially when hard tissues are the targets, 
such as in the case of bone. The control of the 
mechanical properties of the scaffolds aiming 
at matching the mechanical environment of the 
host tissues has been a subject of great attention 
over the last years [16,32,33]. In this sense, we 
have envisioned the use of high-concentration 
aqueous SF solution as a possible strategy to 
improve the mechanical properties of the SF 
scaffolds. Regarding the dry status properties 
of the silk/nano-CaP scaffolds, it is possible to 
state that the addition and increasing content 
of CaP particles in the SF scaffolds showed no 
statistical differences for the control, silk/CaP-
4, silk/CaP-8 and silk/CaP-16 (Figure 8a & B), 
indicating that the nucleation and growth 
of the nano-sized CaP particles within the 
SF scaffolds did not compromise its dry-state 
mechanical performance in this study. The 
DMA data indicated that the control, silk/CaP-
4, silk/CaP-8 and silk/CaP-16 possessed good 
elasticity and stable viscosity, as their storage 
modulus increased with the increase of the 
frequency, and their loss factors were between 
1.6 and 0.2 (Figure 9). The storage modulus 
(wet state) of the silk/nano-CaP scaffolds 
presented porosity dependence when the initially 
incorporated CaP content was comprised 
between 4 and 16 wt.%. The storage modulus of 
silk/CaP-8 is comparable to that of the control, 
while silk/CaP-16 presented a higher value. 
These results demonstrated that the mechanical 
performance of the silk-based scaffolds (wet 
state) can be maintained or even improved after 
incorporation of a certain amount of nano-sized 
CaP in the salt-leached SF scaffolds.
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Figure 10.(A) Hydration degree and (B) weight loss ratio of the silk and silk/nano-sized calcium phosphate scaffolds 
determined by immersion in sodium chloride solution at 37°C (60 rpm) for different time periods.  
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/nano-CaP scaffold with 4 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin).
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As compared with the mechanical properties 
of silk/CaP scaffolds reported from other 
studies, silk/CaP-16 prepared in this study 
possessed a compressive modulus of around 19 
MPa, which is approximately five-times higher 
than the highest one reported by Liu et al. [31]. 
In their study, the highest compressive modulus 
of the silk/HA scaffolds was around 3.2 MPa. By 
its turn, the compressive modulus of silk/CaP-16 
was around nine-times higher to that of the salt-
leached SF scaffolds coated with a biomimetic 
CaP layer developed by Kim et al. [15]. The 
compressive modulus in that study was about 
2 MPa. By comparing the compressive strength 
of silk/CaP-16 (0.62 MPa) to other studies, our 
value was around seven-times and three-times 
higher as compared with those reported by 
Zhang et al. [17] and Kim et al. [15], respectively. 
In their studies, the compressive strengths of the 
scaffolds were approximately 80 and 150 kPa, 
respectively. However, the mechanical properties 
of scaffolds prepared in this study are inferior as 
compared with cross-linked silk/CaP scaffolds 
reported by Collins et al. [16]. In their study, 
the chemical cross-linking was performed by 
using hexamethylene diisocyanate to endow 
the scaffolds with mechanical performance 
comparable to that of cancellous bone, with 
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Figure 11. Mineralization of the silk/nano-sized calcium phosphate porous scaffolds determined by scanning electron 
microscopy and energy dispersive x-ray detector, after immersion in a simulated body fluid solution for 7 days.  
(A), (B), (C) and (d) are the scanning electron microscopy images of the mineral on the surface of silk/CaP-4, silk/CaP-8, silk/CaP-16 
and silk/CaP-25, respectively. (e), (F), (G) and (H) are energy dispersive x-ray detector spectra corresponding to (A), (B), (C) and (d), 
respectively. 
Silk/nano-CaP: Scaffolds composed of silk fibroin and nano-sized calcium phosphate; silk/CaP-4: Silk/nano-CaP scaffold with 4 wt.% 
initially theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-8: Silk/nano-CaP scaffold with 8 wt.% initially 
theoretically incorporated CaP (divided by the mass of silk fibroin); silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin); silk/CaP-25: Silk/nano-CaP scaffold with 25 wt.% initially theoretically 
incorporated CaP (divided by the mass of silk fibroin).
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an average compressive modulus of 175 MPa 
and strengths of 14 MPa. The size of the 
interconnected pores of those scaffolds was 
relatively lower (50–100 mm) compared with 
the one in this study (around 500 mm). The 
lower pore sizes may also be contributed to the 
outstanding mechanical performance of the silk/
CaP scaffolds developed in their study. However, 
this approach is a little risky; the residual of the 
hexamethylene diisocyanate must be removed 
completely and the safety of the degradation 
products should also be investigated.
The hydration behavior and the degradation 
ratio of the scaffold are also critical to the cell 
attachment, proliferation and the final outcome 
of the regenerated tissue. The hydration ratio 
of the silk/nano-CaP scaffolds is related to the 
porosity and structure integrity. From silk/
CaP-4 to silk/CaP-16, the hydration degree 
decreased as the porosity decreased (Figure 10a 
& Figure 5a). Since the integrity of silk/CaP-25 
is lower as compared with the other groups 
(Figure 3), its ability to retain the water inside the 
scaffold also decreased (Figure 10a). The hydration 
degrees of silk/nano-CaP scaffolds demonstrated 
in this study were higher than those reported 
by Liu et al. [31]. In their study, the porosities 
of the silk/CaP scaffolds were between 41 and 
61%, resulting in the lower hydration degrees. 
All the silk/nano-CaP scaffolds showed good 
stability, after 1 month of immersion in a 
sodium chloride solution. This result is related 
to the b-sheet conformation of the SF, which 
conferred good water stability to the silk/
nano-CaP scaffolds. Actually, the degradation 
profiles of silk/nano-CaP scaffolds resemble 
that reported for the control SF scaffolds after 
immersion in ISS for 7 days [18]. Despite this, 
the slight weight loss of the silk/nano-CaP 
scaffolds can be directly related to the partial 
dissolution of the poorly crystalline CaP. In fact, 
small amounts of calcium and phosphate ions 
were detected in the degradation solution of the 
silk/nano-CaP scaffolds by ion-coupled plasma 
(data not shown), in a preliminary study. The 
systematic study of the degradation profile of 
CaP particles in the silk/nano-CaP scaffolds is 
presently ongoing. The release of calcium and 
phosphate ions from the silk/nano-CaP scaffolds 
is viewed as an advantage, as it would promote 
bone regeneration when applied for bone tissue 
engineering, as previously reported by Oliveira 
et al. [2,3], Zhang et al. [17] and Bhumiratana et al. 
[27].
An in vitro bioactivity test performed in 
SBF has been used to predict the in vivo bone 
bioactivity of biomaterials [20]. If a biomaterial 
can induce an apatite layer on its surface in SBF, 
it can probably bond to living bone in vivo. HA 
was found to be bioacitve both in SBF and 
in vivo. The formation of apatite on its surface 
in SBF was due to the dissolution of calcium 
and phosphate ions from HA [21]. In this study, 
nano-sized CaP particles were incorporated into 
the SF scaffolds. The low crystallinity nature of 
these CaP particles allowed the dissolution of 
calcium and phosphate ions in SBF solution, and 
subsequently induced the formation of apatite 
on the surface of the scaffolds. It was noticed 
that silk/nano-CaP scaffolds still presented 
bioactivity even when incorporated with a 
small amount of nano-sized CaP particles; for 
instance, silk/CaP-4. The bioactive nature of 
silk/nano-CaP scaffolds indicates that these 
scaffolds possess great potential for bone tissue 
engineering applications.
The assessment of the cytotoxicity of scaffolds 
by using their extract fluid has been investigated 
in our previous studies [21,25]. Since silk/CaP-16 
presented higher mechanical performance (wet 
state) as compared with other silk/nano-CaP 
scaffolds, it was selected along with the control 
for the cytotoxicity test. The cell viability was 
over 100% in some data points, meaning that 
the leachables from the scaffolds can induce 
higher cell metabolic activity compared with 
normal culture medium. The leachables from 
the SF scaffold were probably composed of 
some small SF nanoparticles, which may act 
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Figure 12. Cytotoxicity assessment of the leachables from control and silk/
CaP-16 using L929 cells. †Indicates significant differences as compared with the 
cell viability at day 1; ‡indicates significant differences as compared to the cell 
viability of the control at all the tested time points, and as well as the cell viability of 
silk/CaP-16 at day 1 and day 3. Extract fluid of latex used as positive control.  
Silk/CaP-16: Silk/nano-CaP scaffold with 16 wt.% initially theoretically incorporated 
CaP (divided by the mass of silk fibroin).
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as a nutrient source for the cells. Similarly, the 
leachables from the silk/nano-CaP scaffolds 
were almost certainly the nano-sized CaP/silk 
composite. The nano-sized particles released 
calcium and phosphate ions, as well as the SF 
fragments. These factors might be helpful to 
increase the cell’s viability. The cell viability 
data clearly demonstrated that the silk/CaP-16 
and the control presented no cytotoxicity, which 
means that there are no toxic traces remaining 
in the scaffolds. This data also validates the 
processing method for the macro/micro porous 
silk and silk/nano-CaP scaffolds.
Conclusion
In this study, macro/micro porous silk/nano-
CaP scaffolds were produced, through the 
in situ synthesis of nano-sized CaP in a high-
concentration aqueous SF solution (16 wt.%) 
followed by scaffolding using a salt-leaching/
lyophilization approach. The CaP particles 
consisted of poorly crystalline HA and the SF 
presented b-sheet conformation. The synergetic 
effect of the in situ synthesis method and the 
highly concentrated SF aqueous solution 
allowed for uniform distribution of the CaP 
particles in the scaffolds, at both microscopic 
and macroscopic scales. The combination of salt-
leaching/lyophilization approaches allowed the 
formation of highly interconnected macro-pores, 
homogeneous porosity distribution, and high 
interconnectivity in the silk/nano-CaP scaffolds. 
The silk/nano-CaP scaffolds with the theoretical 
CaP content of 16 wt.% present the highest 
wet status storage modulus. The porosity and 
hydration degree of the silk/nano-CaP scaffolds 
can be controlled by the amount of CaP particles 
incorporated. The developed silk and silk/nano-
CaP scaffolds are noncytotoxic. The silk/nano-
CaP scaffolds developed present promising 
mechanical properties, architecture and stability, 
bioactivity and no cytotoxicity, which make 
them suitable for possible application in bone 
tissue engineering scaffolding.
Future perspective
By combining the in situ synthesis method 
with the traditional scaffolding approaches, 
bioactive nanocomposite-based scaffold with 
homogeneous distribution of the nano-particles 
was achieved. The incorporation of nano-sized 
CaP particles will endow the SF scaffolds with 
the property of osteoconductivity. Besides 
that, much room remains for the development 
of multi-functional silk/nano-CaP scaffolds 
based on this study. The surface functionality 
of these scaffolds might be helpful to guide the 
cell attachment and migration. By using some 
green chemistries, such as plasma treatment 
and supercritical fluid processing, the surface 
chemistry and surface roughness can be tuned, 
and play an important role in cell behavior. 
executive summary
Bridging of nanoparticles with porous scaffold
  This study presented a good example of how to bridge the nano-sized bioactive particles with a three-dimensional porous scaffold by 
using combined facile approaches, namely in situ synthesis and salt-leaching/lyophilization.
Controlling the size of nano-sized calcium phosphate in silk fibroin
  Nano-sized calcium phosphate (CaP) particles were successfully synthesized in situ in a highly concentrated silk fibroin (SF) aqueous 
solution. The size of the synthesized CaP particles can be controlled at less than 200 nm by varying the amount of CaP incorporated in 
the SF solution.
Homogeneous distribution of nano-CaP
  The in situ synthesis method allowed the homogeneous distribution of the nano-sized CaP within the SF matrix, both at microscopic and 
macroscopic scales.
Superior mechanical properties
  The mechanical performance of the silk/nano-CaP scaffolds can be maintained or improved by the incorporation of different amounts of 
nano-sized CaP particles.
High interconnectivity
  The macro/micro porous structure, along with the high interconnectivity of the silk/nano-CaP scaffolds, make them promising scaffolds 
for bone tissue engineering.
Tunable physicochemical properties
  The porosity and the hydration degree can be tuned by the amount of CaP particles incorporated.
Osteogenesis potential
  All the silk/nano-CaP scaffolds developed in this study were able to induce the formation of apatite on their surface in simulated body 
fluid. The bioactivity of these scaffolds indicates that they possess osteoconductive properties and present osteogenesis potential, which 
is advantageous in bone tissue engineering.
Noncytotoxic
  The developed silk and silk/nano-CaP scaffolds are noncytotoxic.
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Furthermore, the nano-CaP particles also present 
advantages for the affinity of bisphosphonates 
on their surface, such as alendronate and 
zoledronate. Combining the achievement of 
this study, it could even better enhance bone 
regeneration by loading these drugs in the 
nano-CaP particles during the in situ synthesis 
procedure and subsequently incorporating into 
the scaffolds. Other drugs, for instance water-
soluble dexamethasone or antibiotics, could also 
be combined in the scaffolds by this manner, to 
improve the bone repair outcomes.
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